Shaker J L, Redlin K C, Warren G V, Findling J W
Department of Medicine, St. Luke's Medical Center, Milwaukee, Wisconsin 53215.
Am J Med Sci. 1994 Aug;308(2):115-8. doi: 10.1097/00000441-199408000-00011.
Hypercalcemia associated with the extrarenal production of 1,25-dihydroxyvitamin D (1,25(OH)2D) has been reported in several disorders, most notably granulomatous diseases such as sarcoidosis. The authors describe a woman with hypercalcemia, renal insufficiency, microscopic hematuria, and anemia. The circulating 1,25(OH)2D level was higher than appropriate for the ambient conditions (renal insufficiency, suppressed intact parathyroid hormone, and hypercalcemia). A kidney biopsy was consistent with Wegener's granulomatosis, and treatment with prednisone and cyclophosphamide was associated with normalization of serum calcium levels, improved renal function, a marked decrease in serum 1,25(OH)2D levels, and increased serum intact parathyroid hormone levels. These findings are consistent with the unregulated production of 1,25(OH)2D by inflammatory cells associated with Wegener's granulomatosis.
在多种疾病中均有报道与肾外生成1,25 - 二羟维生素D(1,25(OH)₂D)相关的高钙血症,最显著的是结节病等肉芽肿性疾病。作者描述了一名患有高钙血症、肾功能不全、镜下血尿和贫血的女性。循环中的1,25(OH)₂D水平高于与周围环境(肾功能不全、完整甲状旁腺激素受抑制和高钙血症)相适应的水平。肾活检结果符合韦格纳肉芽肿病,使用泼尼松和环磷酰胺治疗后,血清钙水平恢复正常,肾功能改善,血清1,25(OH)₂D水平显著下降,血清完整甲状旁腺激素水平升高。这些发现与韦格纳肉芽肿病相关的炎症细胞不受调控地生成1,25(OH)₂D一致。